Our endometrial cancer nomogram is a prediction tool designed to help patients and their physicians calculate the likely outcome of their primary surgical treatment for endometrial (uterine) cancer.
All results from this tool should be discussed with a physician and understood in the context of each patient’s program of care. Results from the endometrial cancer nomogram are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of uterine cancer procedures. This tool has been externally validated using data from large, independent sets of patients (see Supporting Publications).
Use our Endometrial Cancer: Overall Survival Probability Following Surgery nomogram.